Association of eNOS Gene Polymorphisms G894T and T-786C with Risk of Hepatorenal Syndrome
Table 4
Plasma nitrite levels (μmol/L) in HRS, cirrhosis, and control groups.
Groups
Totally median (Min–Max)
G894T median (Min–Max)
T/C 786 median (Min–Max)
GG
GT
TT
TT
TC
CC
HRS ()
39.7 (31.7–73.6)
<0.001
48.8 (35.3–73.6)
39.5 (34.3–42.7)
32.8 (31.7–39.4)
<0.001
41.5 (34.3–73.6)
39.5 (32.7–48.8)
36 (31.7–46.2)
0.058
Cirrhosis ()
34.5 (28.6–45.6)
35.6 (28.6–45.6)
34.5 (34.3–34.7)
30.9 (30.0–39.8)
0.780
36.1 (30.9–45.6)
33.0 (28.6–37.6)
30.7 (30.0–34.7)
0.029
Control ()
25.4 (20.2–29.7)
25.9 (23.4–29.0)
25.1 (23.1–29.7)
20.2 (20.2–20.2)
0.307
25.4 (23.1–29.7)
25.4 (20.2–28.1)
25.3 (23.6–27.1)
0.992
HRS, hepatorenal syndrome; plasma nitrite level (μmol/L). versus cirrhosis group, versus control group, versus HRS with G894T GG genotype, versus HRS with G894T GT genotype, and versus cirrhosis with T786C TT genotype.
